Effectiveness of Platelet-rich Plasma Treatment of Knee Osteoarthritis

PHASE2RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

Platelet-Rich Plasma

The PRP will be prepared using a single centrifugation process. Approximately 30 ml of peripheral blood will be drawn and collected into a vacutainer tubes with sodium citrate anticoagulant 0.129 mol/l (3.8%). The tubes will then be centrifuged at 900 RPM for 12 minutes at room temperature in a benchtop centrifuge. We will separate the lower third of the plasma fraction from all tubes with a syringe and needle, taking care to avoid the leukocyte layer. The PRP will be refrigerated at 4°C for no less than 1 hour. We will not use any exogenous factors to stimulate the platelet activation process. The periauricular skin surface will be disinfected with a povidone iodine solution, and an intra-articular local anesthetic with 1% lidocaine will be applied. A 21-gauge needle will be placed at the point of application. Finally, PRP will be injected into the joint, and the needle will be removed.

Trial Locations (1)

3100

RECRUITING

Institute for Research and Development in Bioengineering and Bioinformatics (IBB-CONICET-UNER), Oro Verde

All Listed Sponsors
collaborator

National Council of Scientific and Technical Research, Argentina

OTHER_GOV

lead

Universidad Nacional de Entre Rios

OTHER